Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Personalized Treatment of Early Breast Cancer Using Multi-parameter Analysis: Focus on YOUNGer Women

NCT07106632 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT07106632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07106632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Personalized Treatment of Early Breast Cancer Using Multi-parameter Analysis: Focus on YOUNGer Women
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Recruiting
Start date
June 26, 2026
Completion date
August 15, 2038
Enrollment
3,380 (estimated)
Sites
105

Conditions

As the registry lists them; a condition with its own page is linked.

early breast cancer, hr+/her2- breast cancer, premenopausal breast cancer